CARRii’s inaugural annual scientific meeting brought together over 100 researchers, clinicians, innovators and patient partners from across the UK at a critical moment for the health service.

The UK Inhaler Group (UKIG) has produced a practical concise guide to support healthcare professionals in selecting and using spacer and valved holding chamber (VHC) devices for patients with asthma and COPD.

Asthma is a long term condition caused by inflammation of the airways leading to wheeze, cough, breathlessness and chest tightness. It is the most common chronic condition in childhood, affecting around 1.1 million children in the UK, equivalent to three children in every classroom.

CARRii (Centre for Applied Respiratory Research & Innovation) is a UK research centre dedicated to enhancing lung health by supporting the implementation of high-quality research into clinical practice, with the aim of reducing hospital admissions, easing NHS winter healthcare pressures, and

Anaphylaxis is a time-critical emergency. Prompt intramuscular (IM) adrenaline remains the first-line treatment, rapidly reversing airway oedema, vasodilatation and bronchospasm (MHRA, 2023).

Allergic rhinitis (AR) is a common condition affecting between 15-25% of the general population; its symptoms significantly reduce quality of life and pose a high economic burden, including indirect costs related to lost school and workdays. 

Rhinitis is a highly prevalent problem in all age groups that significantly impairs the lives of people with the condition, including their cohabitants. Underdiagnosis and misdiagnosis are common, which leads to under or inappropriate treatment, economic impact, and potential harm. 

Healthcare professionals who are passionate about improving respiratory care are invited to attend the PCRS Respiratory Conference from 24th to 26th of September 2026 at the Telford International Centre.

The Primary Care Respiratory Society UK (PCRS) is increasingly alarmed by the widespread and accelerating loss of respiratory leadership, expertise and strategic capacity across Integrated Care Boards (ICBs), regional NHS structures, and Primary Care Networks (PCNs).

The Asthma Slide Rule supports implementation of the 2024 BTS/NICE/SIGN asthma guideline, greener respiratory healthcare and is a gateway to establishing short-acting beta2-agonist (SABA) free treatment pathways. It should be used:

Since the publication of the Darzi Report and the new NHS 10-year Health Plan: Fit for the Future, there has been an increased focus on the delivery of Neighbourhood Health to reinforce integrated care and facilitate joined-up working between primary, secondary, community and social care.

My name is Russell Winwood; I’m 59 years old and have been living with severe COPD for the past 14 years. Nowadays I live very well with my COPD, but it hasn’t always been like this.

Point-of-care testing of C-reactive protein (CRP) for the acute assessment of worsening symptoms in people known to have COPD can safely reduce the use of antibiotics and could help improve the diagnostic approach towards someone presenting in such a crisis.

In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 and then again in 2023 known as ‘Keeping it S

Winter brings predictable surges in respiratory illness and pressure across urgent and emergency care. This paper sets out a practical, primary care-led framework to reduce avoidable demand by acting earlier on respiratory risk. We describe seven interventions: